BTB09089

Research use only, not for human use.

BTB09089 (GPR65 agonist ) is a T cell death-associated gene 8 (TDAG8/GPR65)-specific agonist.BTB09089 induces TDAG8 expression and regulates cytokine production in T cells and macrophages.

BTB09089 is a T cell death-associated gene 8 (TDAG8/GPR65) specific agonist. BTB09089 increases TDAG8 expression and regulates the cytokine production of T cells and macrophages.

——

Animal Model:Adult male SD rats (270-280 g), middle cerebral artery occlusion (MCAO) model Dosage:5, 10 and 20 μM, 8 μL Administration:Intracerebroventricular injection, six hours prior to MCAO Result:Up-regulated TDAG8 and Bcl-2 expression and down-regulated cleaved caspase-3 expression, while the infarction volume was reduced, and neurological deficits were ameliorated 24 and 72 h after MCAO.

——

Cell Cycle/DNA Damage

GPR

GPR | DNA

——

——

245728-44-3

387.31

C14H12Cl2N4OS2

>98% (HPLC)

In Vitro:?DMSO : 100 mg/mL (258.19 mM; Ultrasonic (<80°C)

CN1C2=C(SC(SCC3=C(Cl)C=C(Cl)C=C3)=N1)C(=O)N(C)N=C2

——

(-20℃)

With Ice Pack

≥ 2 years